Section Arrow
MRK.NYSE
- Merck & Co
Quotes are at least 15-min delayed:2026/03/10 06:01 EDT
Pre Market
Last
 117.48
+0.37 (+0.32%)
Bid
117.19
Ask
117.5
High 117.51 
Low 117.09 
Volume 1.29K 
Regular Hours (Closed)
Last
 117.11
+1.32 (+1.14%)
Day High 
117.26 
Prev. Close
115.79 
1-M High
125.14 
Volume 
8.32M 
Bid
117.19
Ask
117.5
Day Low
114.11 
Open
114.98 
1-M Low
113.82 
Market Cap 
286.28B 
Currency 美元 
P/E 15.9 
%Yield 3.53 
10-SMA 120.67 
20-SMA 120.54 
50-SMA 113.88 
52-W High 125.14 
52-W Low 73.31 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
7.28/10.11
Enterprise Value
333.03B
Balance Sheet
Book Value Per Share
21.28
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
65.01B
Operating Revenue Per Share
23.99
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDCXMedicus Pharma Ltd0.52+0.1348+34.99%-- 
Pre Market 0.5673 +0.0574 +11.26%
PFEPfizer26.81-0.24-0.89%19.84PE
Pre Market 26.88 +0.07 +0.26%
NVONovo-Nordisk A/S39.78+1.2+3.11%10.75PE
Pre Market 39.54 -0.24 -0.60%
BMYBristol-Myers Squibb Co60.63+0.34+0.56%17.41PE
Pre Market 60.63 0 0.00%
MRKMerck & Co117.11+1.32+1.14%15.9PE
Pre Market 117.48 +0.37 +0.32%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographicalperspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.